D-Wave Stock Sits at a Crossroads: Neutral RSI Masks a Week of Scientific Salvos and Record Bookings

D-Wave Quantum shares ended the trading week at €25.80, a modest 2% daily gain that capped a far more eventful five days than the final price suggests. The stock has more than doubled from its 52-week low of €11.32, yet still trades roughly 33% below the year's peak of €38.48. Technically, the rally has left the shares in neutral territory: the relative strength index sits at 49 — well below the 70 threshold that typically flags overbought conditions — while the stock holds 53% above its 50-day moving average and 26% above the 200-day line. That kind of spread indicates real trend strength, but also a significant re-rating that has already been priced in.

A Scientific Dispute That Hits the Investment Case

The most consequential event of the week was not a price swing but a carefully worded statement from D-Wave on May 26. The company pushed back against claims that classical simulations had undermined its previously demonstrated quantum advantage. Researchers had published work that appeared to replicate some of D-Wave’s quantum simulation results using conventional supercomputers, raising questions about the durability of the company’s technological edge.

D-Wave countered that the classical paper did not reproduce the hardest problem instances or the full measurement scope of the original peer-reviewed Science article. The company pointed to calculations involving multiple graph topologies — square, cubic and bipartite — where the largest cases are practically unsolvable with classical methods. For a firm whose valuation premium rests heavily on the belief that its quantum processors deliver commercially relevant performance, this defense is existential. As one analyst might put it, the entire bull case depends on the technology holding up under academic scrutiny.

Mixed Q1 Numbers Mask a Boom in Orders

While the scientific debate dominated headlines, the quarterly results released earlier painted a starkly divided picture. Revenue in the first quarter came in at just $2.9 million, an 81% plunge from the same period a year earlier. That headline number, however, obscures a surge in future business. Bookings soared to $33.4 million from a mere $1.6 million in the prior-year quarter. Remaining performance obligations stood at $42.4 million at the end of March, with about 54% of that expected to convert into revenue within the next twelve months.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

The company’s balance sheet provides a backstop while investors wait to see whether the booking momentum turns into hard revenue growth. D-Wave ended the quarter with $588.4 million in consolidated cash and marketable securities — a 93% increase year-over-year. That liquidity cushion gives the stock a floor, even as the path to sustained profitability remains uncertain.

Investor Day as the Next Catalyst

All of this sets the stage for Monday, June 1, when D-Wave will hold its first-ever investor day at the New York Stock Exchange under the banner “The D-Wave Difference.” The agenda covers technology strategy, product roadmap, commercial traction and long-term growth outlook. For a company that has spent the week defending its scientific credibility while touting record order intake, this event is a chance to weave those two narratives into a coherent story.

Technical resistance sits at $32 (approximately €30 based on the current exchange rate relationship), while support has formed around $23.50 — a level where buyers stepped in during the week’s intraday dip. The annualized volatility of 134% underscores the speculative nature of the stock; the shares have gained roughly 7% year-to-date and 75% over the past twelve months.

D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.

The real test for D-Wave now comes on two fronts: can it convince the academic community that its quantum advantage claims are robust, and can it demonstrate to investors that the $33.4 million in bookings will translate into a visible revenue trajectory in the coming quarters? Monday’s presentation will need to address both — or risk leaving the stock caught between scientific doubt and commercial promise.

Ad

D-Wave Quantum Stock: New Analysis - 30 May

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

en | US26740W1099 | D-WAVE | boerse | 69450629 |